Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gyula Ostoros

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2015
Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung AdenocarcinomaZoltan Lohinai, Mir Alireza Hoda, Katalin Fabian, et al.
Magyar Onkologia|September 23, 2020
[Novel approaches to the epidemiology of lung cancer in Hungary]Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, et al.
Frontiers in Oncology|November 12, 2019
Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From HungaryKrisztina Bogos, Zoltán Kiss, Gabriella Gálffy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2025
Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 StudyJeffrey D Bradley, Shunichi Sugawara, Ki Hyeong Lee, et al.
CA: a Cancer Journal for Clinicians|June 17, 2023
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directionsZsolt Megyesfalvi, Carl M Gay, Helmut Popper, et al.
Cancers|October 12, 2019
KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based ChemotherapyAron Kristof Ghimessy, Aron Gellert, Erzsebet Schlegl, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort studyThomas Klikovits, Zoltán Lohinai, Katalin Fábián, et al.
Pathology Oncology Research : POR|July 14, 2021
Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016Lilla Tamási, Krisztián Horváth, Zoltán Kiss, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2014
Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapyMihaly Cserepes, Gyula Ostoros, Zoltan Lohinai, et al.
Pathology Oncology Research : POR|July 14, 2021
Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016Krisztina Bogos, Zoltan Kiss, Lilla Tamási, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2015
Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung AdenocarcinomaZoltan Lohinai, Mir Alireza Hoda, Katalin Fabian, et al.
Magyar Onkologia|September 23, 2020
[Novel approaches to the epidemiology of lung cancer in Hungary]Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, et al.
Frontiers in Oncology|November 12, 2019
Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From HungaryKrisztina Bogos, Zoltán Kiss, Gabriella Gálffy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2025
Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 StudyJeffrey D Bradley, Shunichi Sugawara, Ki Hyeong Lee, et al.
CA: a Cancer Journal for Clinicians|June 17, 2023
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directionsZsolt Megyesfalvi, Carl M Gay, Helmut Popper, et al.
Cancers|October 12, 2019
KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based ChemotherapyAron Kristof Ghimessy, Aron Gellert, Erzsebet Schlegl, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort studyThomas Klikovits, Zoltán Lohinai, Katalin Fábián, et al.
Pathology Oncology Research : POR|July 14, 2021
Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016Lilla Tamási, Krisztián Horváth, Zoltán Kiss, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2014
Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapyMihaly Cserepes, Gyula Ostoros, Zoltan Lohinai, et al.
Pathology Oncology Research : POR|July 14, 2021
Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016Krisztina Bogos, Zoltan Kiss, Lilla Tamási, et al.
Pageof 6